Bellevue, Washington Clinical Trials

*Healthy Children Studies

Northwest Clinical Research Center

CRPS Treatment Evaluation 1 Study A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered Orally to Subjects with Complex Regional Pain Syndrome Type I (CRPS-I)

Anemia

Research Site

Patients are needed to participate in a clinical research study evaluating Ferric Maltol and Ferric Carboxy Maltose for the treatment of Anemia, Iron-Deficiency, Inflammatory Bowel Disease or Crohn's Disease

Anterior Uveitis

Vitreoretinal Associates of Washington

A clinical trial to evaluate treatments using 4mg CLS-TA Suprachoriodal Injection and Sham Procedure for patients, Non-Infectious Uveitis

Attention Deficit/Hyperactivity Disorder (ADHD - Adults)

Northwest Clinical Research Center Updated

A clinical trial to evaluate treatments using EVO for patients with Attention Deficit Disorder With Hyperactivity

Attention Deficit/Hyperactivity Disorder (ADHD - Pediatric)

Northwest Clinical Research Center

A randomized, controlled parallel-group, intervention study to assess at-home, game-based digital therapy for treating pediatric patients participants ages 8 to 12 years old with Attention Deficit Hyperactivity Disorder (ADHD)

Northwest Clinical Research Center

A Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Titration Study of Methylphenidate Hydrochloride Extended-Release Capsules (Aptensio XR®) in Children Ages 4 to Under 6 Years Diagnosed with Attention Deficit-Hyperactivity Disorder (ADHD)

Autism

Northwest Clinical Research Center

A PHASE II MULTI-CENTER, RANDOMIZED, DOUBLEBLIND, 24-WEEK, 3-ARM, PARALLEL GROUP, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF RO5285119 IN CHILDREN AND ADOLESCENTS AGE 5-17 WITH AUTISM SPECTRUM DISORDER (ASD)

View More »

Northwest Clinical Research Center Updated

A clinical trial seeking patients for a research study for the treatment of Autism Spectrum Disorder

Bipolar Disorder

Investigative Site 004

Patients are needed to participate in a clinical research study of cariprazine and placebo to evaluate Bipolar Disorder or Depression

Breast Cancer

Overlake Medical Center

A clinical research study of paclitaxel, Reparixin and placebo for the treatment of Metastatic Breast Cancer, Triple-Negative Breast Cancer

Chronic Back Pain

Northwest Clinical Research Center

A PHASE 3, RANDOMIZED, DOUBLE BLIND, PLACEBO AND ACTIVE-CONTROLLED, MULTICENTER, PARALLEL-GROUP STUDY OF THE ANALGESIC EFFICACY AND SAFETY OF TANEZUMAB IN ADULT SUBJECTS WITH CHRONIC LOW BACK PAIN

Chronic Pain

Northwest Clinical Research Center

CRPS Treatment Evaluation 1 Study A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered Orally to Subjects with Complex Regional Pain Syndrome Type I (CRPS-I)

View More »

Research Site

Patients are needed to participate in a clinical research study evaluating AXS-02 (oral zoledronate) and Placebo for the treatment of Chronic Regional Pain Syndrome - Type 1 or Reflex Sympathetic Dystrophy (crps-1)

Northwest Clinical Research Center

A clinical research study of NSAID, Tanezumab 2.5 mg and Tanezumab 5 mg for the treatment of Chronic Pain, Osteoarthritis of the Hip or Knee

Constipation

Synergy Pharmaceuticals Inc.

A Phase 3 clinical study for patients with Irritable Bowel Syndrome Characterized by Constipation

COPD (Chronic Obstructive Pulmonary Disease)

Northwest Clinical Research Center

A Randomized, Double-Blind, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT009 Compared to PT005, PT008, and Open-label Symbicort® Turbuhaler®, as an Active Control, on Lung Function over a 24-Week Treatment Period in Subjects With Moderate to Very Severe COPD

View More »

Pearl Investigative Site

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disorder

Pearl Investigative Site

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disorder

Crohn's Disease

Research Site

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Research Site

Patients are needed to participate in a clinical research study evaluating Ferric Maltol and Ferric Carboxy Maltose for the treatment of Anemia, Iron-Deficiency, Inflammatory Bowel Disease or Crohn's Disease

Depression

MMG

Does Your Child Have Depression?

View More »

Research Site

A clinical trial to evaluate treatments using AXS-05 and Bupropion for patients with Treatment Resistant Major Depressive Disorder

Forest Investigative Site 001

A clinical research study of Vilazodone, Placebo and Fluoxetine for the treatment of Major Depressive Disorder

Investigative Site 001

A clinical research study of Vilazodone for the treatment of Major Depressive Disorder

Investigative Site 004

Patients are needed to participate in a clinical research study of cariprazine and placebo to evaluate Bipolar Disorder or Depression

NorthWest Clinical Research Center Updated

Patients are needed to participate in a clinical research study of Rapastinel and Placebo-matching Rapastinel to evaluate Depressive Disorder, Major

NorthWest Clinical Research Center

A clinical trial to evaluate treatments using Rapastinel and Placebo for patients with Depressive Disorder, Major

Northwest Clinical Research Center

A Phase 3 clinical study for patients with Major Depressive Disorder (MDD)

NorthWest Clinical Research Center Updated

Patients are needed to participate in a clinical research study of Rapastinel to evaluate Depressive Disorder, Major

Depression (Adolescent)

MMG

Does Your Child Have Depression?

Northwest Clinical Research Center

A Double-blind, Placebo- and Active-Controlled Evaluation of the Safety and Efficacy of Levomilnacipran ER in Adolescent Patients with Major Depressive Disorder

Depression (Major/Severe)

MMG

Does Your Child Have Depression?

Depression (Pediatric)

Northwest Clinical Research Center

A Multicenter, Double-blind, Placebo- and Active-Controlled Parallel-Group Evaluation of the Safety and Efficacy of Vilazodone in Pediatric Patients With Major Depressive Disorder

Depression (Treatment-Resistant)

Northwest Clinical Research Center

A Randomized, Double-blind, Active-controlled Trial to Assess the Efficacy and Safety of AXS-05 Administered Orally to Subjects with Treatment Resistant Major Depressive Disorder

Northwest Clinical Research Center

A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder

Diabetes (Pediatric)

Northwest Clinical Research Center

A Randomized, Double-Blind Study with an Open-Label Extension Comparing the Effect of Once-Weekly Dulaglutide with Placebo in Pediatric Patients with Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2

Northwest Clinical Research Center Updated

A clinical research study of Dulaglutide and Placebo for the treatment of Type 2 Diabetes

Novo Nordisk Investigational Site Updated

Patients are needed to participate in a clinical research study to evaluate Diabetes or Diabetes Mellitus, Type 2

Dyskinesias

Neurocrine Clinical Site Updated

Patients are needed to participate in a clinical research study to evaluate Tardive Dyskinesia

Glaucoma

Specialty Eye Care

A clinical trial to evaluate treatments using Glaucoma Surgery and InnFocus MicroShunt for patients with Primary Open Angle Glaucoma

Specialty Eyecare Centre

Patients are needed to participate in a clinical research study evaluating Bimatoprost sustained-release, Sham, Timolol and Timolol Vehicle (placebo) for the treatment of Glaucoma, Open-Angle or Ocular Hypertension

Heart Attack (Myocardial Infarction)

Novartis Investigative Site

A Phase 3 clinical study for patients with Acute Myocardial Infarction

Hemodialysis

Lake Washington Vascular Center

Patients are needed to participate in a clinical research study evaluating Vonapanitase and Placebo for the treatment of Chronic Kidney Disease (CKD)

Hemorrhage

Lake Washington Vascular

A clinical research study of CELSTAT and Surgicel Original for the treatment of Bleeding Active

Hernia

Overlake Hospital

A clinical study for patients with Hernia, Ventral or Incisional Hernia

High Blood Pressure (Hypertension)

Specialty Eyecare Centre

Patients are needed to participate in a clinical research study evaluating Bimatoprost sustained-release, Sham, Timolol and Timolol Vehicle (placebo) for the treatment of Glaucoma, Open-Angle or Ocular Hypertension

Inflammatory Bowel Disease

Research Site

Patients are needed to participate in a clinical research study evaluating Ferric Maltol and Ferric Carboxy Maltose for the treatment of Anemia, Iron-Deficiency, Inflammatory Bowel Disease or Crohn's Disease

Research Site

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Kidney Disease

Lake Washington Vascular Center

Patients are needed to participate in a clinical research study evaluating Vonapanitase and Placebo for the treatment of Chronic Kidney Disease (CKD)

Lung Disease

Pearl Investigative Site

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disorder

Pearl Investigative Site

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disorder

Macular Degeneration

Vitreoretinal Associates of Washington

A Phase 3 clinical study for patients with Geographic Atrophy

Macular Edema

Vitreoretinal Associates of Washington

A clinical trial to evaluate treatments using 4mg CLS-TA Suprachoriodal Injection and Sham Procedure for patients, Non-Infectious Uveitis

Migraine and Cluster Headaches

Northwest Clinical Research Center

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients with Chronic Migraine – the REGAIN Study

Northwest Clinical Research Center

A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED SINGLE ATTACK STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF ORAL UBROGEPANT IN THE ACUTE TREATMENT OF MIGRAINE

Northwest Clinical Research Center

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients with Episodic Cluster Headaches

Northwest Clinical Research Center

A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF MULTIPLE DOSING REGIMENS OF ORAL AGN-241689 IN EPISODIC MIGRAINE PREVENTION

Northwest Clinical Research Center

A Parallel Group Double-Blind Randomized Placebo Controlled Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients with Frequent Episodic Migraines

Ocular Hypertension

Specialty Eyecare Centre

Patients are needed to participate in a clinical research study evaluating Bimatoprost sustained-release, Sham, Timolol and Timolol Vehicle (placebo) for the treatment of Glaucoma, Open-Angle or Ocular Hypertension

Osteoarthritis

Northwest Clinical Research Center

A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY OF THE ANALGESIC EFFICACY AND SAFETY OF A DOSE TITRATION REGIMEN FOR THE SUBCUTANEOUS ADMINISTRATION OF TANEZUMAB IN SUBJECTS WITH OSTEOARTHRITIS OF THE HIP OR KNEE

Northwest Clinical Research Center

A Randomized, Double-Blind, Placebo-controlled trial to assess the efficacy and safety of AXS-02 (disodium zoledronate tetrahydrate) administered orally to subjects with knee osteoarthritis associated with bone marrow lesions.

Northwest Clinical Research Center

A PHASE 3 RANDOMIZED, DOUBLE-BLIND, ACTIVE-CONTROLLED, MULTICENTER STUDY OF THE LONG-TERM SAFETY AND EFFICACY OF SUBCUTANEOUS ADMINISTRATION OF TANEZUMAB IN SUBJECTS WITH OSTEOARTHRITIS OF THE HIP OR KNEE

View More »

Northwest Clinical Research Center

A clinical trial to evaluate treatments using Placebo, Tanezumab 2.5 mg and Tanezumab 2.5mg/5mg for patients with Osteoarthritis, Knee or Osteoarthritis, Hip

Northwest Clinical Research Center Updated

Patients are needed to participate in a clinical research study of Investigational Medical Product (IMP) administered in parent study to evaluate Osteoarthritis

Northwest Clinical Research Center

A clinical research study of NSAID, Tanezumab 2.5 mg and Tanezumab 5 mg for the treatment of Chronic Pain, Osteoarthritis of the Hip or Knee

Northwest Clinical Research Center Updated

A clinical research study of Ampion and Saline for the treatment of Osteoarthritis, Knee, Knee Osteoarthritis, Knee Arthritis or Knee Pain Chronic

Pain

Northwest Clinical Research Center

A PHASE 3, RANDOMIZED, DOUBLE BLIND, PLACEBO AND ACTIVE-CONTROLLED, MULTICENTER, PARALLEL-GROUP STUDY OF THE ANALGESIC EFFICACY AND SAFETY OF TANEZUMAB IN ADULT SUBJECTS WITH CHRONIC LOW BACK PAIN

Northwest Clinical Research Center

CRPS Treatment Evaluation 1 Study A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered Orally to Subjects with Complex Regional Pain Syndrome Type I (CRPS-I)

Polyps

Investigational Site Number 8400010

A clinical trial to evaluate treatments using Dupilumab SAR231893 (REGN668), Placebo and Mometasone furoate nasal spray for patients with Nasal Polyps

Posterior Uveitis

Vitreoretinal Associates of Washington

A clinical trial to evaluate treatments using 4mg CLS-TA Suprachoriodal Injection and Sham Procedure for patients, Non-Infectious Uveitis

Schizophrenia and Schizoaffective Disorders

Northwest Clinical Research Center

A phase II randomised, double-blinded, placebo-controlled parallel group trial to examine the efficacy and safety of 4 oral doses of BI 425809 once daily over 12 week treatment period in patients with Schizophrenia

Northwest Clinical Research Center

A 12 WEEK, PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED, PARALLEL GROUP STUDY TO EVALUATE THE SAFETY AND EFFICACY OF PF-04958242 IN SUBJECTS WITH COGNITIVE IMPAIRMENT ASSOCIATED WITH SCHIZOPHRENIA (CIAS)

View More »

Alkermes Investigational Site

Patients are needed to participate in a clinical research study of ALKS 3831 and Olanzapine to evaluate Schizophrenia

Tardive Dyskinesia

Northwest Clinical Research Center

Real-World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents

View More »

Neurocrine Clinical Site Updated

Patients are needed to participate in a clinical research study to evaluate Tardive Dyskinesia

Ulcerative Colitis

Northwest Gastroenterology Associates

A clinical trial to evaluate treatments using etrolizumab for patients with Ulcerative Colitis

Northwest Gastroenterology Associates

A Phase 3 clinical study for patients with Ulcerative Colitis

Northwest Gastroenterology Associates

A clinical trial seeking patients for a research study for the treatment of Ulcerative Colitis

Ulcers

Northwest Gastroenterology Associates

A clinical trial to evaluate treatments using etrolizumab for patients with Ulcerative Colitis

Northwest Gastroenterology Associates

A Phase 3 clinical study for patients with Ulcerative Colitis

Northwest Gastroenterology Associates

A clinical trial seeking patients for a research study for the treatment of Ulcerative Colitis

Uveitis

Vitreoretinal Associates of Washington

A clinical trial to evaluate treatments using 4mg CLS-TA Suprachoriodal Injection and Sham Procedure for patients, Non-Infectious Uveitis